Table 2.
Participants characteristics at enrolment by site location. PrEP Brasil-2015
| Participant’s characteristics | Total | RJ | SP | Chi-Square |
|---|---|---|---|---|
| Overall | 4501 | 180 (40.0%) | 270 (60%) | <0.01 |
| Socio-demographics2 | ||||
| Age | 0.02 | |||
| 18–24 years | 113 | 58 (32.2%) | 55 (20.4%) | |
| 25–35 years | 214 | 76 (42.2%) | 138 (51.1%) | |
| ≥35 years | 123 | 46 (25.6%) | 77 (28.5%) | |
| Colour/Race | <0.01 | |||
| White | 243 | 60 (33.5%) | 183 (68.8%) | |
| Black | 57 | 41 (22.9%) | 16 (6.0%) | |
| Mixed Race | 145 | 78 (43.6%) | 67 (25.2%) | |
| Schooling | <0.01 | |||
| <12 years | 115 | 81 (45.0%) | 34 (12.6%) | |
| ≥12 years | 335 | 99 (55.0%) | 236 (87.4%) | |
| Gender | <0.01 | |||
| Male | 425 | 161 (89.4%) | 265 (97.8%) | |
| Trans women | 25 | 19 (10.6%) | 6 (2.2%) | |
| Housing situation | <0.01 | |||
| Rent or own housing | 289 | 98 (55.7%) | 191 (71.5%) | |
| Other (live with friends/family, live in public housing) | 154 | 78 (44.3%) | 76 (28.5%) | |
| Steady partner | 0.51 | |||
| Yes | 254 | 105 (58.3%) | 149 (55.2%) | |
| No | 196 | 75 (41.7%) | 121 (44.8%) | |
| Sexual behaviour in last 3 months | ||||
| Had sex with client | 0.63 | |||
| Yes | 27 | 12 (6.7%) | 15 (5.6%) | |
| No | 423 | 168 (93.3%) | 255 (94.4%) | |
| Unprotected receptive anal intercourse | 0.28 | |||
| Yes | 201 | 86 (47.8%) | 115 (42.6%) | |
| No | 249 | 94 (52.2%) | 155 (57.4%) | |
| Sex with HIV-positive partners | 0.11 | |||
| Yes | 223 | 80 (46.5%) | 143 (54.4%) | |
| No | 212 | 92 (53.5%) | 120 (45.6%) | |
| Median Number of male partners (IQR) | 3 (1–10) | 3 (1–10) | 4 (1–10) | 0.22 3 |
| Sexual role with male partners | 0.29 | |||
| Insertive | 112 | 41 (23.0%) | 71 (26.6%) | |
| Receptive | 49 | 16 (9.0%) | 33 (12.4%) | |
| Both | 284 | 121 (68.0%) | 163 (61.0%) | |
| Substance use and mental health | ||||
| Binge drinking | 0.91 | |||
| Yes | 266 | 107 (59.4%) | 159 (58.9%) | |
| No | 184 | 73 (40.6%) | 111 (41.1%) | |
| Any illicit drug use in past 3 months | 0.05 | |||
| Yes | 134 | 44 (24.7%) | 90 (33.5%) | |
| No | 313 | 134 (75.3%) | 179 (66.5%) | |
| Marijuana | 0.19 | |||
| Yes | 128 | 45 (25.0%) | 83 (30.7%) | |
| No | 322 | 135 (75.0%) | 187 (69.3%) | |
| Stimulants (cocaine, crack, amphetamines) | 0.01 | |||
| Yes | 62 | 16 (8.9%) | 46 (17.0%) | |
| No | 388 | 164 (91.1%) | 224 (83.0%) | |
| Hallucinogens (solvents, LSD, ketamine) | 0.45 | |||
| Yes | 38 | 13 (7.2%) | 25 (9.3%) | |
| No | 412 | 167 (92.8%) | 245 (90.7%) | |
| Tranquilizers | 0.44 | |||
| Yes | 30 | 10 (5.6%) | 20 (7.4%) | |
| No | 420 | 170 (94.4%) | 250 (92.6%) | |
| Erectile dysfunction drugs | 0.10 | |||
| Yes | 51 | 15 (8.3%) | 36 (13.3%) | |
| No | 399 | 165 (91.7%) | 234 (86.7%) | |
| Depression PHQ score | 0.62 | |||
| PHQ-2 score ≥ 3 | 27 | 12 (6.7%) | 15 (5.6%) | |
| PHQ-2 score < 3 | 422 | 167 (93.3%) | 255 (94.4%) | |
| STD diagnosis | 0.87 | |||
| Yes | 89 | 35 (19.7%) | 54 (20.3%) | |
| No | 355 | 143 (80.3%) | 212 (79.7%) | |
| Active/recent syphilis2 | 0.94 | |||
| Yes | 43 | 17 (9.6%) | 26 (9.8%) | |
| No | 401 | 161 (90.4%) | 240 (90.2%) | |
| Chlamydia | 0.05 | |||
| Yes | 36 | 9 (5.1%) | 27 (10.2%) | |
| No | 408 | 169 (94.9%) | 239 (89.8%) | |
| Gonorrhoea | 0.33 | |||
| Yes | 22 | 11 (6.2%) | 11 (4.1%) | |
| No | 422 | 167 (93.8%) | 255 (95.9%) | |
| Risk perception | ||||
| Number of HIV tests in 12 months prior inclusion | <0.01 | |||
| 0 | 76 | 52 (32.7%) | 24 (10.4%) | |
| 1–3 | 235 | 91 (57.2%) | 144 (62.3%) | |
| >3 | 79 | 16 (10.1%) | 63 (27.3%) | |
| PEP in 12 months prior inclusion | 0.34 | |||
| Yes | 91 | 33 (20.9%) | 58 (25.0%) | |
| No | 299 | 125 (79.1%) | 174 (75.0%) | |
| Any GI symptoms2 | 0.01 | |||
| Yes | 178 | 40 (24.1%) | 138 (53.5%) | |
| No | 246 | 126 (75.9%) | 120 (46.5%) | |
TGW= Transgender women, STD =Sexually transmitted diseases, RJ= Rio de Janeiro, SP= São Paulo, PHQ= Patient Health Questionnaire, GI= Gastrointestinal. PEP = Post exposure prophylaxis. 1There was missing information for: Housing situation (n = 7), Sexual role with male (n = 5), Any illicit drug use in last 3 months (n = 3), STDs (n = 6), Number of HIV tests in 12 months prior inclusion (n = 60), PEP in 12 months prior inclusion (n = 60). 5 individuals who reported yellow/indigenous are not included in this table. 2Socio-demogrphics, except “Housing situation”, were assessed at pre-screening visit. Syphilis was assessed at screening visit and GI symptoms, at week 4. All other variables are from enrolment visit. 3Kruskal-Wallis Test.